Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Brian M. Stuglik, R.Ph.$249.2M
Market Cap • 19/04/20242010
(há 14 anos)
2012
(12 years ago)
NASDAQ
Listagem
Needham
Sede • Massachusetts57
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
VSTMSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.